会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Nucleic acid molecule capable of binding to c-Met and use thereof
    • 能够结合c-Met的核酸分子及其用途
    • US08822667B2
    • 2014-09-02
    • US13812190
    • 2011-07-26
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • C07H21/04C07H21/02A61K48/00
    • C07H21/02A61K31/52A61K31/7105C12N15/115C12N2310/16C12Q1/6883C12Q2525/301C12Q2527/125A61K2300/00
    • The present invention provides a nucleic acid molecule capable of binding to c-Met as a substance that can be used for clarification of the pathogenic mechanism of diseases caused by c-Met, diagnosis and treatment of the diseases, and the like, and also the use thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following nucleic acid molecules (A1), (A2), (B1), and (B2). (A1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 1 to 38 (A2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 1 to 38 (B1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 39 to 76 (B2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 39 to 76.
    • 本发明提供能够结合c-Met的核酸分子,作为能够用于澄清由c-Met,疾病的诊断和治疗等引起的疾病的致病机制的物质,以及 使用它。 本发明的c-Met结合核酸分子是以下核酸分子(A1),(A2),(B1)和(B2)中的任一种。 (A1)包含SEQ ID NO:1至38(A2)中任一个的碱基序列的核酸分子,其能够结合c-Met并包含通过取代,缺失,加成获得的碱基序列 ,(SEQ ID NO:39)至(38)中的任何一个的碱基序列的核酸分子,和/或在SEQ ID NO:1至38(B1)中任一个的碱基序列中插入一个或多个碱基, 能够结合c-Met的核酸分子,并且包含通过SEQ ID NO:39至76中任一个的碱基序列中的一个或多个碱基的取代,缺失,添加和/或插入获得的碱基序列 。
    • 4. 发明申请
    • APTAMER THAT RECOGNIZES PEPTIDE
    • 认可肽的APTAMER
    • US20120129720A1
    • 2012-05-24
    • US13320462
    • 2010-05-14
    • Shotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • Shotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • C40B30/04C12N15/63C12N15/115C07H21/02
    • C12N15/115C07H21/02C12N15/1048C12N15/113C12N2310/113C12N2310/16C12N2320/50
    • An aptamer capable of binding to a histidine peptide is provided. A nucleic acid used as the aptamer capable of binding to a histidine peptide is any of the following nucleic acids (a) to (d): (a) a nucleic acid having a base sequence represented by SEQ ID NO: 17: GGUNnAYUmGGH (SEQ ID NO: 17), where in the nucleic acid (a), N represents A, G, C, U, or T, n of Nn represents the number of Ns and is an integer from 1 to 3, Y represents U, T, or C, m of Um represents the number of Us and is an integer from 1 to 3, and H represents U, T, C, or A; (b) a nucleic acid having a base sequence obtained by substitution, deletion, addition, or insertion of one or more bases in a base sequence of the nucleic acid (a) and being capable of binding to the histidine peptide; (c) a nucleic acid having a base sequence represented by SEQ ID NO: 18: GGCGCCUUCGUGGAAUGUC (SEQ ID NO: 18); and (d) a nucleic acid having a base sequence obtained by substitution, deletion, addition, or insertion of one or more bases in a base sequence of the nucleic acid (c) and being capable of binding to the histidine peptide.
    • 提供了能够结合组氨酸肽的适体。 用作能够结合组氨酸肽的适体的核酸是以下任一核酸(a)至(d):(a)具有由SEQ ID NO:17表示的碱基序列的核酸:GGUNnAYUmGGH(SEQ ID NO: ID号:17),其中在核酸(a)中,N表示A,G,C,U或T,N n表示N的数,为1〜3的整数,Y表示U,T 或C m表示Us的数,是1〜3的整数,H表示U,T,C或A; (b)具有通过在核酸(a)的碱基序列中取代,缺失,添加或插入一个或多个碱基并且能够结合组氨酸肽而获得的碱基序列的核酸; (c)具有由SEQ ID NO:18表示的碱基序列的核酸:GGCGCCUUCGUGGAAUGUC(SEQ ID NO:18); 和(d)具有通过在核酸(c)的碱基序列中取代,缺失,添加或插入一个或多个碱基并且能够结合组氨酸肽而获得的碱基序列的核酸。
    • 5. 发明申请
    • PREDICTION DEVICE, PREDICTION METHOD, PROGRAM, AND RECORDING MEDIUM
    • 预测装置,预测方法,程序和记录介质
    • US20130102480A1
    • 2013-04-25
    • US13807876
    • 2011-07-02
    • Jou AkitomiShintarou KatouShotaro TsujiTakashi OhtsuIwao Waga
    • Jou AkitomiShintarou KatouShotaro TsujiTakashi OhtsuIwao Waga
    • G06F19/16
    • G06F19/16C12N15/115C12N2310/16G06F19/18
    • The present invention provides a prediction device, a prediction method, a program, and a recording medium, with which whether or not desired aptamer sequences are enriched can be predicted easily. The prediction device of the present invention 10 includes an input unit 11, a calculation unit 12, and a prediction unit 13. The input unit 11 is a unit through which sequence information on a target aptamer sequence group including selected aptamers in a target pool and a reference aptamer sequence group including reference aptamer sequences are inputted. The calculation unit 12 calculates the free energy of the target aptamer sequence group and the free energy of the reference aptamer sequence group. The prediction unit 13 compares the free energy of these sequence groups, and predicts that the target pool is an enriched pool when the free energy of the target aptamer sequence group is lower than the free energy of the reference aptamer sequence group. The reference aptamer sequence group is a candidate aptamer sequence group including a plurality of candidate aptamer sequences or a virtual aptamer sequence group that is derived from the target aptamer sequence group and includes virtual aptamer sequences having the same base composition as the target aptamer sequence group.
    • 本发明提供一种预测装置,预测方法,程序和记录介质,可以容易地预测其中是否需要富集需要的适体序列。 本发明的预测装置10包括输入单元11,计算单元12和预测单元13.输入单元11是通过目标池中包括所选择的适配体的目标适体序列组的序列信息和 输入包括参考适体序列的参照适体序列组。 计算单元12计算目标适体序列组的自由能和参考适体序列组的自由能。 预测单元13比较这些序列组的自由能,并且当靶适体序列组的自由能低于参考适体序列组的自由能时,预测目标池是富集池。 参照适体序列组是包含从目标适体序列组得到的多个候选适体序列或虚拟适体序列组的候选适体序列组,并且具有与靶适体序列组相同的基本组成的虚拟适配子序列。
    • 6. 发明申请
    • NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-MET AND USE THEREOF
    • 可以与C-MET结合的核酸分子和其使用
    • US20130123350A1
    • 2013-05-16
    • US13812190
    • 2011-07-26
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • C07H21/02
    • C07H21/02A61K31/52A61K31/7105C12N15/115C12N2310/16C12Q1/6883C12Q2525/301C12Q2527/125A61K2300/00
    • The present invention provides a nucleic acid molecule capable of binding to c-Met as a substance that can be used for clarification of the pathogenic mechanism of diseases caused by c-Met, diagnosis and treatment of the diseases, and the like, and also the use thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following nucleic acid molecules (A1), (A2), (B1), and (B2).(A1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 1 to 38 (A2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 1 to 38 (B1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 39 to 76 (B2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 39 to 76
    • 本发明提供能够结合c-Met的核酸分子,作为能够用于澄清由c-Met,疾病的诊断和治疗等引起的疾病的致病机制的物质,以及 使用它。 本发明的c-Met结合核酸分子是以下核酸分子(A1),(A2),(B1)和(B2)中的任一种。 (A1)包含SEQ ID NO:1至38(A2)中任一个的碱基序列的核酸分子,其能够结合c-Met并包含通过取代,缺失,加成获得的碱基序列 ,(SEQ ID NO:39)至(38)中的任何一个的碱基序列的核酸分子,和/或在SEQ ID NO:1至38(B1)中任一个的碱基序列中插入一个或多个碱基, 能够结合c-Met的核酸分子,并且包含通过SEQ ID NO:39至76中任一个的碱基序列中的一个或多个碱基的取代,缺失,添加和/或插入获得的碱基序列
    • 8. 发明授权
    • Prediction device, prediction method, program, and recording medium
    • 预测装置,预测方法,程序和记录介质
    • US09454642B2
    • 2016-09-27
    • US13807876
    • 2011-07-02
    • Jou AkitomiShintarou KatouShotaro TsujiIwao Waga
    • Jou AkitomiShintarou KatouShotaro TsujiTakashi OhtsuIwao Waga
    • G01N33/50G06F19/16C12N15/115G06F19/18
    • G06F19/16C12N15/115C12N2310/16G06F19/18
    • The present invention provides a prediction device, a prediction method, a program, and a recording medium, with which whether or not desired aptamer sequences are enriched can be predicted easily. The prediction device of the present invention 10 includes an input unit 11, a calculation unit 12, and a prediction unit 13. The input unit 11 is a unit through which sequence information on a target aptamer sequence group including selected aptamers in a target pool and a reference aptamer sequence group including reference aptamer sequences are inputted. The calculation unit 12 calculates the free energy of the target aptamer sequence group and the free energy of the reference aptamer sequence group. The prediction unit 13 compares the free energy of these sequence groups, and predicts that the target pool is an enriched pool when the free energy of the target aptamer sequence group is lower than the free energy of the reference aptamer sequence group. The reference aptamer sequence group is a candidate aptamer sequence group including a plurality of candidate aptamer sequences or a virtual aptamer sequence group that is derived from the target aptamer sequence group and includes virtual aptamer sequences having the same base composition as the target aptamer sequence group.
    • 本发明提供一种预测装置,预测方法,程序和记录介质,可以容易地预测其中是否需要富集需要的适体序列。 本发明的预测装置10包括输入单元11,计算单元12和预测单元13.输入单元11是通过目标池中包括所选择的适配体的目标适体序列组的序列信息和 输入包括参考适体序列的参照适体序列组。 计算单元12计算目标适体序列组的自由能和参考适体序列组的自由能。 预测单元13比较这些序列组的自由能,并且当靶适体序列组的自由能低于参考适体序列组的自由能时,预测目标池是富集池。 参照适体序列组是包含从目标适体序列组得到的多个候选适体序列或虚拟适体序列组的候选适体序列组,并且具有与靶适体序列组相同的基本组成的虚拟适配子序列。